← Leaderboards
John J Laterra
Hugo W. Moser Res Inst Kennedy Krieger
$16,027,154
Attributed
$17,285,644
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$17,285,644 · 8
By mechanism
R01$17,285,644 · 8
Top collaborators
- Eliot M Rosen5 shared
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaGlioblastomaTumorMolecularMalignant NeoplasmsGene ExpressionIn VivoCellsXenograft ProcedureResistanceAnimalsStemGrowthMalignant Neoplasm Of BrainTranscription FactorHepatocyte Growth FactorResponseSignal PathwayGenetic TranscriptionOncogenicNeoplastic CellNovel StrategiesInhibitor/AntagonistPhenotype
Grant awards (49)
Tet2 regulation and function in glioma cell phenotype reprogramming$353,500
R01 · FY2023 · NS · contact PI
Tet2 regulation and function in glioma cell phenotype reprogramming$353,500
R01 · FY2022 · NS · contact PI
Chromatin Modifications in GBM-Propagating Cells$399,522
R01 · FY2021 · NS · contact PI
Tet2 regulation and function in glioma cell phenotype reprogramming$353,500
R01 · FY2021 · NS · contact PI
Chromatin Modifications in GBM-Propagating Cells$470,805
R01 · FY2020 · NS · contact PI
Tet2 regulation and function in glioma cell phenotype reprogramming$353,500
R01 · FY2020 · NS · contact PI
Chromatin Modifications in GBM-Propagating Cells$484,224
R01 · FY2019 · NS · contact PI
Tet2 regulation and function in glioma cell phenotype reprogramming$353,500
R01 · FY2019 · NS · contact PI
Chromatin Modifications in GBM-Propagating Cells$453,788
R01 · FY2018 · NS · contact PI
Chromatin Modifications in GBM-Propagating Cells$418,103
R01 · FY2017 · NS · contact PI
Brain Cancer Stem Cell Reprogramming by c-Met$353,569
R01 · FY2016 · NS · contact PI
Brain Cancer Stem Cell Reprogramming by c-Met$353,567
R01 · FY2015 · NS · contact PI
Suppression of Glioblastoma Stem Cells by Kruppel-Like Factor 9$323,357
R01 · FY2015 · NS · contact PI
Brain Cancer Stem Cell Reprogramming by c-Met$350,030
R01 · FY2014 · NS · contact PI
Suppression of Glioblastoma Stem Cells by Kruppel-Like Factor 9$320,942
R01 · FY2014 · NS · contact PI
Brain Cancer Stem Cell Reprogramming by c-Met$341,190
R01 · FY2013 · NS · contact PI
Suppression of Glioblastoma Stem Cells by Kruppel-Like Factor 9$312,665
R01 · FY2013 · NS · contact PI
Mechanisms of Chemo/Radioresistance in Human Gliomas$500,361
R01 · FY2012 · NS · contact PI
Brain Cancer Stem Cell Reprogramming by c-Met$353,500
R01 · FY2012 · NS · contact PI
Suppression of Glioblastoma Stem Cells by Kruppel-Like Factor 9$323,982
R01 · FY2012 · NS · contact PI
Mechanisms of Chemo/Radioresistance in Human Gliomas$501,160
R01 · FY2011 · NS · contact PI
Suppression of Glioblastoma Stem Cells by Kruppel-Like Factor 9$308,416
R01 · FY2011 · NS · contact PI
Mechanisms of Chemo/Radioresistance in Human Gliomas$507,095
R01 · FY2010 · NS · contact PI
Neutralizing Anti-HGF mAbs and CNS Malignancy$306,637
R01 · FY2010 · CA · contact PI
Mechanisms of Chemo/Radioresistance in Human Gliomas$499,834
R01 · FY2009 · NS · contact PI
Neutralizing Anti-HGF mAbs and CNS Malignancy$306,623
R01 · FY2009 · CA · contact PI
Mechanisms of Chemo/Radioresistance in Human Gliomas$508,530
R01 · FY2008 · NS · contact PI
Neutralizing Anti-HGF mAbs and CNS Malignancy$306,609
R01 · FY2008 · CA · contact PI
Mechanisms of Chemo/Radioresistance in Human Gliomas$488,678
R01 · FY2007 · NS · contact PI
Biochemistry of Brain Tumor Microvessel Development$362,561
R01 · FY2007 · NS · contact PI
Neutralizing Anti-HGF mAbs and CNS Malignancy$305,829
R01 · FY2007 · CA · contact PI
Mechanisms of Chemo/Radioresistance in Human Gliomas$488,618
R01 · FY2006 · NS · contact PI
Biochemistry of Brain Tumor Microvessel Development$373,389
R01 · FY2006 · NS · contact PI
Mechanisms of Chemo/Radioresistance in Human Gliomas$485,801
R01 · FY2005 · NS
Biochemistry of Brain Tumor Microvessel Development$382,375
R01 · FY2005 · NS
Mechanisms of Chemo/Radioresistance in Human Gliomas$479,667
R01 · FY2004 · NS
Biochemistry of Brain Tumor Microvessel Development$382,375
R01 · FY2004 · NS
Mechanisms of Chemo/Radioresistance in Human Gliomas$475,915
R01 · FY2003 · NS
Biochemistry of Brain Tumor Microvessel Development$380,637
R01 · FY2003 · NS
Biochemistry of Brain Tumor Microvessel Development$80,500
R01 · FY2003 · NS
Mechanisms of Chemo/Radioresistance in Human Gliomas$8,015
R01 · FY2003 · NS
BIOCHEMISTRY OF BRAIN TUMOR MICROVESSEL DEVELOPMENT$287,199
R01 · FY2002 · NS
THERAPEUTIC ANGIOGENESIS FOR ISCHEMIC DISEASES OF BRAIN$270,166
R01 · FY2002 · HL
BIOCHEMISTRY OF BRAIN TUMOR MICROVESSEL DEVELOPMENT$323,727
R01 · FY2001 · NS
THERAPEUTIC ANGIOGENESIS FOR ISCHEMIC DISEASES OF BRAIN$264,174
R01 · FY2001 · HL
BIOCHEMISTRY OF BRAIN TUMOR MICROVESSEL DEVELOPMENT$314,297
R01 · FY2000 · NS
THERAPEUTIC ANGIOGENESIS FOR ISCHEMIC DISEASES OF BRAIN$258,357
R01 · FY2000 · HL
BIOCHEMISTRY OF BRAIN TUMOR MICROVESSEL DEVELOPMENT$51,355
R01 · FY2000 · NS
BIOCHEMISTRY OF BRAIN TUMOR MICROVESSEL DEVELOPMENT$50,000
R01 · FY2000 · NS